Genmab AS

Genmab AS Profit per Employee

The Profit per Employee of Genmab AS (GMAB) as of Nov 22, 2026 is 318,177.45 USD. In the previous year, Profit per Employee was 2.59 M USD — a change of -87.71% (lower).

Profit per Employee

318,177.45USD

YoY

-87.71%

Last updated:

Profit per Employee of Genmab AS is 2025 318,177.45 USD. Profit per Employee of Genmab AS was 2024 2.59 M USD. It decreases by -87.71% lower compared to the previous year.

The Genmab AS Profit per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Profit per Employee
Date
Profit per Employee
Jan 1, 2018
486,015.52 USD
Jan 1, 2019
715,087.49 USD
Jan 1, 2020
1.57 M USD
Jan 1, 2021
976,229.78 USD
Jan 1, 2022
1.80 M USD
Jan 1, 2023
1.44 M USD
Jan 1, 2024
2.59 M USD
Jan 1, 2025
318,177.45 USD
The Genmab AS Profit per Employee history
YEARProfit per EmployeeYoY
318,177.45USD-87.71%
2.59 MUSD+80.24%
1.44 MUSD-20.18%
1.80 MUSD+84.38%
976,229.78USD-37.85%
1.57 MUSD+119.67%
715,087.49USD+47.13%
486,015.52USD+33.40%
364,328.49USD-7.04%
391,903.27USD+55.48%
252,067.68USD+153.41%
99,470.45USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab AS stock

Profit per Employee of Genmab AS is 318,177.45 USD in 2025.

Profit per Employee of Genmab AS changed from 2.59 M USD to 318,177.45 USD, representing a -87.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Profit per Employee Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Profit per employee measures how much net income each employee generates on average. It is a key indicator of workforce efficiency.

Profit per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Profit per Employee's Genmab AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Genmab AS

All Key Metrics — Genmab AS